Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-09-06
2005-09-06
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S004100, C536S017200, C536S018400
Reexamination Certificate
active
06939857
ABSTRACT:
Compounds having a mimetic or antagonistic property of an inositol phosphoglycan, and the uses of these compounds are disclosed, together with the use, e.g. to treat a condition ameliorated by administration of an IPG second messenger or an IPG antagonist thereof. Preferred compounds of the invention are based on the substituted cyclitols, such as the chiro-inositol derivative pinitol (3-O-methyl-chiro-inositol).
REFERENCES:
patent: 5268272 (1993-12-01), Mullner et al.
patent: 5395828 (1995-03-01), Schiebler et al.
patent: 5550166 (1996-08-01), Ostlund et al.
patent: 5652221 (1997-07-01), Larner et al.
patent: 6004938 (1999-12-01), Frick et al.
patent: 0 520 372 (1992-12-01), None
patent: 63196596 (1988-08-01), None
patent: 03237101 (1991-10-01), None
patent: 04120089 (1992-04-01), None
patent: 06293790 (1994-10-01), None
patent: WO 96/14075 (1996-05-01), None
patent: WO 98/10791 (1998-03-01), None
patent: WO 98/11116 (1998-03-01), None
patent: WO 98/11117 (1998-03-01), None
patent: WO 98/11435 (1998-03-01), None
patent: WO 98/50049 (1998-11-01), None
patent: WO 99/06421 (1999-02-01), None
patent: WO 99/38516 (1999-08-01), None
patent: WO 99/06421 (1999-11-01), None
patent: WO 00/15254 (2000-03-01), None
patent: WO 00/39141 (2000-07-01), None
Schweizer et al, J. Sci. Food. Agric. 1978, 29(2), 148-154.
Arthur Crossman et al “Synthesis of same second generation substrate analogues of early intermediates in the biosynthetic pathway of glycophosphatidylinositol membrane anchors”, 1999, vol. 321, pp 42-51.
Robert Plourde et al “synthesis of Potentially Insulin Mimetic Phosphodisaccharide”, 1990, vol. 31, No. 19, pp. 2693-2696.
Fernandez De La Pradilla, R. et al., “Improved preparation of acetals of myo-inositol and its (±)-1-benzyl ether: conformational analysis of di-O-isopropylidene-myo-inositol derivatives”; Carbohydrate Research, 207: 249-257 (1990).
Bernabé, M. et al., “Chiral recognition of 1-O-allyl and 1-O-benzyl-D- and -L- myo-inositol by cyclomalto-hexaose and -heptaose (α-and β-cyclodextrin)”; Carbohydrate Research, 208: 255-259 (1990).
Zapata, A. et al., “Novel Highly Regioselective O-Alkylation and O-Acylation of myo-Inositol”; J. Org. Chem., 56: 444-447 (1991).
Jaramillo, C. et al., “Synthesis of 1D-1,2-anhydro-myo-inositol”; Carbohydrate Research, 209: 296-298 (1991).
Jaramillo, C. et al., “Approaches to the Synthesis of Glycosyl Phosphatidyl Inositols. Enantioselective Synthesis of Optically Active chiro- and myo-Inositols.”; Tetrahedron Letters, 32(22): 2501-2504 (1991).
Vasella, A. et al., “194. Convenient Synthesis of 2-Azido-2-deoxy-aldoses by Diazo Transfer”; Helvetica Chimica Acta, 74: 2073-2077 (1991).
Aguiló, A. et al., “The Regioselective Synthesis of Enantiomerically Pure myo-Inositol Derivatives. Efficient Synthesis of myo-Inositol 1,4,5-trisphosphate.”; Tetrahedron Letters, 33(3): 401-404 (1992).
Zapata, A. et al., “Builing blocks for the synthesis of glycosyl-myo-inositols involved in the insulin intracellular signalling process”; Carbohydrate Research, 234: 93-106 (1992).
Caro, H. et al., “Synthesis and insulin-like activity of phosphorylated galactose derivatives”; Carbohydrate Research, 240: 119-131 (1993).
Singh, K. et al., “Synthesis of Oligosaccarides Structurally Related to E-Selectin Ligands”; J. Chem. Soc., Chem. Commun., 775-776 (1994).
Chiara, J.L. et al., “A Stereoselective Route to Enantiomerically Pure myo-Inositol Derivatives Starting from D-Mannitol”; Tetrahedron Letters, 35(18): 2969-2972 (1994).
Zapata, A. et al., “Synthesis and investigation of the possible insulin-like activity of 1D-4-O-and 1D-6-O-(2-amino-2-deoxy-β-D-glucopyranosyl)- myo-inositol 1-phosphate and 1D-6-O-(2-amino-2-deoxy-α-D- glucopyranosyl)- myo-inositol 1,2-(cyclic phosphate)”; Carbohydrate Research, 264: 21-31 (1994).
Jaramillo, C. et al., “An Effective Strategy for the Synthesis of 6-O-(2-Amino-2-deoxy-α-D-glucopyranosyl)-D-chiro- and -D-myo-inositol 1-Phosphate Related to Putative Insulin Mimetics”; J. Org. Chem., 59: 3135-3141 (1994).
Varela-Nieto, I. et al., “Cell Signalling by Inositol Phosphoglycans from Different Species”; Comp. Biochem. Physiol., 115B(2): 223-241 (1996).
Martin-Lomas, M. et al., “The solution conformation of glycosyl inositols related to inositolphosphoglycan (IPG) mediators”; Tetrahedron: Asymmetry, 11: 37-51 (2000).
Baeschlin, D.K. et al., “1,2-Diacetals in Synthesis: Total Synthesis of a Glycosylphosphatidylinositol Anchor ofTrypanosoma brucei”; Chem. Eur. J., 6(1): 172-186 (2000).
Frick, W. et al., “Structure-Activity Relationship of Synthetic Phosphoinositolglycans Mimicking Metabolic Insulin Action”; Biochemistry, 37(38): 13421-13436 (1998).
Jaworek, C.H. et al., “Synthesis of an Inositol-Containing Trisaccharide Related to Insulin Signal Transduction”; Tetrahedron Letters, 40: 667-670 (1999).
Deeg, M.A. et al., “Inositol Glycan Phosphate Derived from Human Erythrocyte Acetylcholinesterase Glycolipid Anchor and Inositol Cyclic 1,2-Phosphate Antagonize Glucagon Activation of Glycogen Phosphorylase”; Diabetes, 42(9): 1318-1323 (1993).
Güther, M.L.S. et al., “Molecular species analysis and quantification of the glycosylphosphatidylinositol intermediate glycolipid C fromTrypsanosoma brucei”; Mol. Biochem. Parasitol., 77(2): 137-145 (1996).
Mayer, T.G. et al., “Glycosyl Phosphatidylinositol (GPI) Anchor Synthesis Based on Versatile Building Blocks—Total Synthesis of a GPI Anchor of Yeast”; Eur. J. Org. Chem. 1153-1165 (1999).
Müller, G. et al., “Phosphoinositolglycan-Peptides from Yeast Potently Induce Metabolic Insulin Actions in Isolated Rat Adipocytes, Cardiomyocytes, and Diaphragms”; Endocrinology, 138: 3459-3475 (1997).
Baeschlin, D.K. et al., “Rapid Assembly of Oligosaccharides: Total Synthesis of a Glycosylphosphatidylinositol Anchor ofTrypanosoma brucei”; Angew. Chem. Int. Ed., 37(24): 3423-3427 (1998).
Derappe, C. et al., “Characterization of a New Oligosaccharide Containing myo-Inositol Found in Pregnancy Urine”; Carbohydrate Research, 115: 221-229 (1983).
Angyal, S.J. et al., “Cyclitols. Part XXII. Synthesis of Some Mannosyl- and Mannosyl-mannosyl-myoinositols, and of Galactinol”; J. Chem. Soc. (C), 433-438 (1966).
Reddy, K.K. et al., “Insulin Second Messengers: Synthesis of 6-O-(2-Amino-2-deoxy-α-D-glucopyranosyl)-D-chiro-inositol-1-phosphate”; Tetrahedron Lets., 34(49): 7869-7872 (1993).
Plourde, R. et al., “Synthesis of a Potentially Insulin-Mimetic Phosphodisaccharide”, Tetrahedron Lets., 31(19): 2693-2696 (1990).
Stralfors, P., “Insulin second messengers”; Bioessays, 19: 327-335 (1997).
Field, M.C., “Is there evidence for phospho-oligosaccharides as insulin mediators?”; Glycobiology, 7: 161-168 (1997).
Jones, D.R. et al., “The role of glycosyl-phosphatidylinositol in signal transduction”; Int. J. Biochem. Cell Biol., 30: 313-326 (1998).
Mato, J.M. et al., “Partial Structure of an Insulin-Sensitive Glycophospholipid”; Biochem. Biophys. Res. Commun., 146: 764-770 (1987).
Larner, J., “Rat Liver Insulin Mediator Which Stimulates Pyruvate Dehydrogenase Phosphatase Contains Galactosamine and D-Chiroinositol”; Biochem. Biophys. Res. Commun., 151: 1416-1426 (1988).
Caro, H.N. et al., “Isolation and Partial Characterisation of Insulin-Mimetic Inositol Phosphoglycans from Human Liver”; Biochem. Mol. Med., 61: 214-228 (1997).
Gigg, R. et al., “Synthesis of Glycosylphosphatidylinositol Anchors”; in “Glycopeptides and Related Compounds”; Large & Warren, Eds., Marcel Dekker, New York, 327-392 (1997).
Corey, E.J. et al., “Protection of Hydroxyl Group
Caro Hugo Norberto
Francois Irene
Martin-Lomas Manuel
Rademacher Thomas William
Dann Dorfman Herrell & Skillman P.C.
Krishnan Ganapathy
Rodaris Pharmaceuticals Limited
Wilson James O.
LandOfFree
Compounds and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3381443